Evogene Receives Nasdaq Noncompliance Notification, Gets Time Through Sept. 28 To Regain Compliance

Evogene Ltd. (NASDAQ: EVGN) has received a notification from Nasdaq regarding noncompliance with Rule 5550(a)(2) due to its ordinary shares closing bid price being below $1.00 for 30 consecutive business days. The company has been granted a 180-day period to regain compliance, with a deadline set for September 28, 2026. To comply, Evogene must maintain a closing bid price of at least $1.00 for ten consecutive business days during this period.